Evidence map›Paper›PMID 21763168›Full record

Trial reportMolecular genetics and metabolism2011

Impaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variant.

Melanie B Gillingham, Matthew Hirschfeld, Sarah Lowe, Dietrich Matern, James Shoemaker, William E Lambert, David M Koeller

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Molecular genetics and metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00653666 (Metabolic Consequences of CPT1A Deficiency in Alaska Native Children), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00653666 nacompletednot on this map

Metabolic Consequences of CPT1A Deficiency in Alaska Native Children

TypeinterventionalSponsorOregon Health and Science UniversityRan2007 to 2009Enrolled12ConditionsCarnitine Palmitoyl Transferase Type 1A (CPT1A) DeficiencyArmsMedically supervised fasting
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. A mild phenotype associated withFrontiers in pediatrics · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Association of theFrontiers in pediatrics · 2021
    Article
  11. Review
  12. Fatty acid oxidation disorders.Annals of translational medicine · 2018
    Review
  13. Response to Koeller et al.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  14. Health effects of the CPT1A P479L variant: responsible public health policy.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  15. Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Review
  16. Evidence for an association between infant mortality and homozygosity for the arctic variant of carnitine palmitoyltransferase 1A.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Melanie B GillinghamDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA. gillingm@ohsu.edu
Matthew Hirschfeld
Sarah Lowe
Dietrich Matern
James Shoemaker
William E Lambert
David M Koeller
Oregon Health & Science University · USAlaska Native Medical Center · USMayo Clinic · USSaint Louis University · US

Funding

OREGON CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024140 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2006 to 2011
$61.1M
Fatty Acid Oxidation Disorders & Body Weight RegulationK01DK071869 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI GILLINGHAM, MELANIE B · 2006 to 2009
$421k
NCRR NIH HHS UL1 RR024140NCRR NIH HHS ULI RR024140NIDDK NIH HHS DK071869NIDDK NIH HHS K01 DK071869
6 · The paper itself

Abstract

A high prevalence of the sequence variant c.1436C→T in the CPT1A gene has been identified among Alaska Native newborns but the clinical implications of this variant are unknown. We conducted medically supervised fasts in 5 children homozygous for the c.1436C→T variant. Plasma free fatty acids increased normally in these children but their long-chain acylcarnitine and ketone production was significantly blunted. The fast was terminated early in two subjects due to symptoms of hypoglycemia. Homozygosity for the c.1436C→T sequence variant of CPT1A impairs fasting ketogenesis, and can cause hypoketotic hypoglycemia in young children. Trial registration www.clinical trials.gov NCT00653666 "Metabolic Consequences of CPT1A Deficiency"

Indexed as

AlaskaAmerican Indian or Alaska NativeBody Mass IndexCarnitineCarnitine O-PalmitoyltransferaseChild, PreschoolFatty Acids, NonesterifiedGas Chromatography-Mass SpectrometryHomozygoteHumansHypoglycemiaKetonesLipid Metabolism, Inborn ErrorsPolymorphism, Single NucleotideTandem Mass SpectrometryacylcarnitineCarnitineCarnitine O-PalmitoyltransferaseFatty Acids, NonesterifiedKetones

Identifiers

PMID21763168
PMCPMC3197793
OpenAlexW2019671343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.